Live from the NIH registry
Studies recruiting near Santa Maria right now
Top 25 of 92 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Sansum Clinic — Solvang, California (29.1 mi)
· Sponsor: Pfizer
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Pacific Central Coast Health Center-San Luis Obispo — San Luis Obispo, California (27.1 mi)
· Sponsor: SWOG Cancer Research Network
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: National Cancer Institute LAO
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Phase 2
Interventional 30 participants sought
Tri Valley Neurology Medical Associates Inc. — Mission Hills, California (17.1 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Santa Maria, California (1.4 mi)
· Sponsor: Akero Therapeutics, Inc
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)
N/A
Interventional 978 participants sought
California Polytechnic State University — San Luis Obispo, California (27.1 mi)
· Sponsor: California Polytechnic State University-San Luis Obispo
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Arthritis Medical Center — Nipomo, California (7.8 mi)
· Sponsor: University of Alabama at Birmingham
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Santa Maria, California (1.4 mi)
· Sponsor: GlaxoSmithKline
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
Phase 3
Interventional 700 participants sought
Research Site — San Luis Obispo, California (27.1 mi)
· Sponsor: AstraZeneca
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor
Phase 2
Interventional 141 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 840 participants sought
Research Site — Solvang, California (29.1 mi)
· Sponsor: AstraZeneca
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
FOMAT - Comprehensive Cardiovascular Care-Santa Maria California — Santa Maria, California (1.4 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Cutaneous Melanoma
Phase 3
Interventional 428 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 10,450 participants sought
FOMAT Medical Research - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Eli Lilly and Company
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Canadian Cancer Trials Group
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
Family Communications After Genetic Testing
Colon Adenocarcinoma, Colorectal Adenocarcinoma
N/A
Interventional 4,186 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology